Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Research & Development Feature Trailer 2019 - Medical Product Outsourcing

What are you searching for?

Sign in
Videos

Research & Development Feature Trailer 2019

Medtech R&D is no longer the private, highly secretive, core competency-focused architect of such blockbusters as the cardiac pacemaker or aluminum splints.

By: Michael Barbella

Managing Editor, Rodman Media

Medtech R&D is no longer the private, highly secretive, core competency-focused architect of such blockbusters as the cardiac pacemaker, aluminum splints, sterile sutures, and oscillating saw. That breed of research and development began fading into oblivion around the turn of the millennium.

In its place is a more social, open-minded model willing to partner or purchase its way to product differentiation. Inspired (more likely forced) by the shift to value-based care, companies are now more willing than ever to seek other ways to innovate.

Acquisitions have become a popular product development strategy, as it quickly and easily gives device firms access to desired technologies outside their core competencies. Medtronic has employed this tactic countless times throughout its history, most recently with last year’s $1.64 billion purchase of Israeli-based Mazor Robotics Ltd., maker of robotic surgical systems for brain and spine procedures.

Click here to read the full article.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters

Topics